MD371Z5 - Method for treating the ocular tuberculosis - Google Patents

Method for treating the ocular tuberculosis

Info

Publication number
MD371Z5
MD371Z5 MDS20100195A MDS20100195A MD371Z5 MD 371 Z5 MD371 Z5 MD 371Z5 MD S20100195 A MDS20100195 A MD S20100195A MD S20100195 A MDS20100195 A MD S20100195A MD 371 Z5 MD371 Z5 MD 371Z5
Authority
MD
Moldova
Prior art keywords
isoniazid
treating
ocular tuberculosis
rifampicin
months
Prior art date
Application number
MDS20100195A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Эльвира ВЕЛИКСАР
Николае ЕЛАШКУ
Original Assignee
Общественное Медико-Санитарное Учреждение Институт Фтизиопневмологии Кирила Драганюка
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общественное Медико-Санитарное Учреждение Институт Фтизиопневмологии Кирила Драганюка filed Critical Общественное Медико-Санитарное Учреждение Институт Фтизиопневмологии Кирила Драганюка
Priority to MDS20100195A priority Critical patent/MD371Z5/en
Publication of MD371Y publication Critical patent/MD371Y/en
Publication of MD371Z publication Critical patent/MD371Z/en
Publication of MD371Z5 publication Critical patent/MD371Z5/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, in particular to ophthalmology and phthisiology and is intended for the treatment of ocular tuberculosis.According to the invention, the claimed method consists in that on both sides in the region of mastoid process, parallel to the auricle subcutaneously is sequantially administered a mixture of 0.01...0.02 ml of heparin of 5000 IU/ml and 2.0 ml of 0.5% novocain, then 1.0...3.0 ml of a solution of 10% isoniazid, in a day, 10...15 procedures, at the same time, concomitantly is administered per os mildronate 250 mg twice a day, isoniazid 300 mg/kg, rifampicin 600 mg/kg, pyrazinamide 1.5 mg/kg, daily, during 2 months, and the next 4 months is administered per os isoniazid 300 mg/kg and rifampicin 600 mg/kg, daily.
MDS20100195A 2010-11-22 2010-11-22 Method for treating the ocular tuberculosis MD371Z5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100195A MD371Z5 (en) 2010-11-22 2010-11-22 Method for treating the ocular tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100195A MD371Z5 (en) 2010-11-22 2010-11-22 Method for treating the ocular tuberculosis

Publications (3)

Publication Number Publication Date
MD371Y MD371Y (en) 2011-05-31
MD371Z MD371Z (en) 2012-04-30
MD371Z5 true MD371Z5 (en) 2012-04-30

Family

ID=45815149

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100195A MD371Z5 (en) 2010-11-22 2010-11-22 Method for treating the ocular tuberculosis

Country Status (1)

Country Link
MD (1) MD371Z5 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2107480C1 (en) * 1996-11-22 1998-03-27 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Method for treating endogenous and postoperative uveitis
RU2189801C2 (en) * 2000-10-17 2002-09-27 Новокузнецкий государственный институт усовершенствования врачей Method for treating anterior uveitis
RU2290191C2 (en) * 2004-07-12 2006-12-27 Федеральное государственное учреждение туберкулезный санаторий "Выборг-3" Федерального агентства по здравоохранению и социальному развитию (ФГУ ТС "Выборг-3" Росздрава") Method for treatment of tuberculosis uveitis
RU2299065C1 (en) * 2005-11-11 2007-05-20 Федеральное государственое учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Агентства по здравоохранению и социальному развитию" Method for treating patients for recurrent uveitis
RU2318534C2 (en) * 2006-03-27 2008-03-10 Федеральное государственное учреждение туберкулезный санаторий "Выборг-3" Федерального агентства по здравоохранению и социальному развитию Method for treating tuberculous uveites

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2107480C1 (en) * 1996-11-22 1998-03-27 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Method for treating endogenous and postoperative uveitis
RU2189801C2 (en) * 2000-10-17 2002-09-27 Новокузнецкий государственный институт усовершенствования врачей Method for treating anterior uveitis
RU2290191C2 (en) * 2004-07-12 2006-12-27 Федеральное государственное учреждение туберкулезный санаторий "Выборг-3" Федерального агентства по здравоохранению и социальному развитию (ФГУ ТС "Выборг-3" Росздрава") Method for treatment of tuberculosis uveitis
RU2299065C1 (en) * 2005-11-11 2007-05-20 Федеральное государственое учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Агентства по здравоохранению и социальному развитию" Method for treating patients for recurrent uveitis
RU2318534C2 (en) * 2006-03-27 2008-03-10 Федеральное государственное учреждение туберкулезный санаторий "Выборг-3" Федерального агентства по здравоохранению и социальному развитию Method for treating tuberculous uveites

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
активными формами туберкулеза органа зрения. II Съезд фтизиатров и пульмонологов ССР Молдовы. Эпидимиология, диагностика, *
Елашку Н. И, Джугостран В. Я, Смольницкая Г. И, Елашку Е. Н, Гуцу Т. А. Лимфотропная терапия в комплексном лечении больных *
Елашку Н. И., Джугостран В. Я., Смольницкая Г. И., Елашку Е. Н., Гуцу Т. А. Лимфотропная терапия в комплексном лечении больных активными формами туберкулеза органа зрения. II Съезд фтизиатров и пульмонологов ССР Молдовы. Эпидимиология, диагностика, клиника и лечение туберкулеза и неспецифических заболеваний легких. 1991, стр. 179 *
клиника и лечение туберкулеза и неспецифических заболеваний легких. 1991. стр. 179. *

Also Published As

Publication number Publication date
MD371Y (en) 2011-05-31
MD371Z (en) 2012-04-30

Similar Documents

Publication Publication Date Title
MX2023008716A (en) Camptothecin compound, preparation method therefor, and application thereof.
EP4233861A3 (en) Compositions for treatment of essential tremor
MX2019014410A (en) Methods of treating fabry patients having renal impairment.
MX338554B (en) Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain.
MX2011007854A (en) Methods for treating acute myocardial infarctions and associated disorders.
RU2017134443A (en) METHOD OF TREATMENT WITH USE OF TRADIPTANT
PH12015501373A1 (en) Injectable depot formulation comprising optically active tolvaptan and process of producing the same
PH12015500653A1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
MX2009007723A (en) Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes.
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
NZ751972A (en) Treatment of prurigo nodularis
AU2012207301A8 (en) Apolipoprotein AIV as an antidiabetic peptide
MD371Y (en) Method for treating the ocular tuberculosis
MX2016014740A (en) A method for treating movement disorders with befiradol.
MD4639B1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
MX2012005497A (en) Tivozanib and temsirolimus in combination.
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
EP4374918A3 (en) Methods of treating fabry patients having renal impairment
MX2021004463A (en) Arginine depletion therapy for treatment of gamt deficiency.
MX2020000514A (en) Methods for treating congenital hyperinsulinism.
MX2016006256A (en) Treatment of glaucoma using laquinimod.
MX344112B (en) Method and device for treating blood cholesterol disorders.
MX2023009600A (en) Oxa-ibogaine analogues for treatment of substance use disorders.
TW202440104A (en) Methods of treating fabry patients having renal impairment
WO2024173750A3 (en) Use of (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid for gastrointestinal tract disorders and as an immunomodulatory agent

Legal Events

Date Code Title Description
ND4Y Validity of short term patent extended [from 6 to 10 years]

Expiry date: 20201122

KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
NF4Y Restoration of lapsed short term patent
MK4Y Short term patent expired